Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial
The BEGONIA trial, a randomized controlled study published in the Journal of Sexual Medicine in 2013 (PMID: 23672269), evaluated the efficacy of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD). The study found that a nightly 100 mg dose of flibanserin significantly increased satisfying sexual events and enhanced
June 26, 2025
No Comments